NVO vs. KKR
NVO (Novo Nordisk A/S) and KKR (KKR & Co. Inc.) are both stocks. NVO operates in Drug Manufacturers - General (Healthcare), while KKR operates in Asset Management (Financial Services). Over the past 10 years, NVO returned 8.18%/yr vs 23.37%/yr for KKR. At a 0.27 correlation, their price movements are largely independent.
Performance
NVO vs. KKR - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, NVO achieves a 0.91% return, which is significantly higher than KKR's -23.41% return. Over the past 10 years, NVO has underperformed KKR with an annualized return of 8.18%, while KKR has yielded a comparatively higher 23.37% annualized return.
NVO
- 1D
- -1.41%
- 1M
- 14.86%
- 6M
- -17.63%
- YTD
- 0.91%
- 1Y
- -19.26%
- 3Y*
- -13.51%
- 5Y*
- 4.43%
- 10Y*
- 8.18%
- ALL TIME*
- 14.52%
KKR
- 1D
- -3.93%
- 1M
- -0.04%
- 6M
- -25.71%
- YTD
- -23.41%
- 1Y
- -32.93%
- 3Y*
- 17.97%
- 5Y*
- 11.31%
- 10Y*
- 23.37%
- ALL TIME*
- 19.00%
NVO vs. KKR - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
NVO Novo Nordisk A/S | 0.91% | -39.22% | -15.93% | 54.84% | 22.66% | 63.52% | 23.33% | 28.70% | -12.98% | 52.92% |
KKR KKR & Co. Inc. | -23.41% | -13.32% | 79.65% | 80.48% | -36.98% | 85.76% | 41.13% | 51.57% | -4.28% | 41.78% |
Correlation
The correlation between NVO and KKR is 0.30, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.30 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.26 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.29 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.25 |
Correlation (All Time) Calculated using the full available price history since Jul 15, 2010 | 0.27 |
Fundamentals
NVO:
$220.46B
KKR:
$87.07B
NVO:
DKK 27.42
KKR:
$3.10
NVO:
11.83
KKR:
31.26
NVO:
0.51
KKR:
3.30
NVO:
4.40
KKR:
4.63
NVO:
7.11
KKR:
1.15
NVO:
DKK 327.80B
KKR:
$19.99B
NVO:
DKK 268.30B
KKR:
$8.35B
NVO:
DKK 181.54B
KKR:
$9.97B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
NVO vs. KKR — Risk / Return Rank
NVO
KKR
NVO vs. KKR - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Novo Nordisk A/S (NVO) and KKR & Co. Inc. (KKR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| NVO | KKR | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.51 | ||
| Sortino ratioReturn per unit of downside risk | +0.98 | ||
| Omega ratioGain probability vs. loss probability | 0.97 | 0.86 | +0.11 |
| Calmar ratioReturn relative to maximum drawdown | -0.39 | -0.74 | +0.35 |
| Martin ratioReturn relative to average drawdown | -0.61 | -1.22 | +0.61 |
Loading charts...
Drawdowns
NVO vs. KKR - Drawdown Comparison
The maximum NVO drawdown since its inception was -74.70%, which is greater than KKR's maximum drawdown of -53.10%. Use the drawdown chart below to compare losses from any high point for NVO and KKR.
Loading charts...
Drawdown Indicators
| NVO | KKR | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -74.70% | -53.10% | -21.60% |
Max Drawdown (1Y)Largest decline over 1 year | -49.17% | -44.62% | -4.55% |
Max Drawdown (3Y)Largest decline over 3 years | -74.70% | -49.42% | -25.28% |
Max Drawdown (5Y)Largest decline over 5 years | -74.70% | -49.42% | -25.28% |
Max Drawdown (10Y)Largest decline over 10 years | -74.70% | -49.42% | -25.28% |
Current DrawdownCurrent decline from peak | -63.95% | -41.23% | -22.72% |
Average DrawdownAverage peak-to-trough decline | -17.89% | -16.37% | -1.52% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 31.75% | 27.11% | +4.64% |
Volatility
NVO vs. KKR - Volatility Comparison
The current volatility for Novo Nordisk A/S (NVO) is 9.48%, while KKR & Co. Inc. (KKR) has a volatility of 10.12%. This indicates that NVO experiences smaller price fluctuations and is considered to be less risky than KKR based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| NVO | KKR | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 9.48% | 10.12% | -0.64% |
Volatility (6M)Calculated over the trailing 6-month period | 37.43% | 29.81% | +7.62% |
Volatility (1Y)Calculated over the trailing 1-year period | 51.79% | 37.26% | +14.53% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 38.58% | 39.39% | -0.81% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 32.63% | 36.60% | -3.97% |
Dividends
NVO vs. KKR - Dividend Comparison
NVO's dividend yield for the trailing twelve months is around 3.63%, more than KKR's 1.07% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
KKR KKR & Co. Inc. | 1.07% | 0.57% | 0.47% | 0.78% | 1.31% | 0.77% | 1.31% | 1.71% | 3.23% | 3.18% | 4.16% | 10.13% |
NVO Novo Nordisk A/S | 3.63% | 3.31% | 1.68% | 1.00% | 1.20% | 1.35% | 1.87% | 2.14% | 1.45% | 1.52% | 2.87% | 0.92% |
Financials
NVO vs. KKR - Financials Comparison
This section allows you to compare key financial metrics between Novo Nordisk A/S and KKR & Co. Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
NVO vs. KKR - Profitability Comparison
NVO - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, Novo Nordisk A/S reported a gross profit of 83.23B and revenue of 96.82B. Therefore, the gross margin over that period was 86.0%.
KKR - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, KKR & Co. Inc. reported a gross profit of 3.98B and revenue of 4.00B. Therefore, the gross margin over that period was 99.5%.
NVO - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, Novo Nordisk A/S reported an operating income of 59.62B and revenue of 96.82B, resulting in an operating margin of 61.6%.
KKR - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, KKR & Co. Inc. reported an operating income of 205.35M and revenue of 4.00B, resulting in an operating margin of 5.1%.
NVO - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, Novo Nordisk A/S reported a net income of 48.56B and revenue of 96.82B, resulting in a net margin of 50.2%.
KKR - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, KKR & Co. Inc. reported a net income of 405.23M and revenue of 4.00B, resulting in a net margin of 10.1%.
Frequently Asked Questions
NVO and KKR have a correlation of 0.30, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
KKR has higher volatility (10.12%) compared to NVO (9.48%). In terms of maximum drawdown, NVO dropped -74.70% vs KKR's -53.10%.
NVO currently has the higher Sharpe Ratio (-0.37 vs -0.89), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for NVO and KKR
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer